Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gisbert

Showing results (61-70 of 211) with videos related to

Pageof 22
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 20, 2004
Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatmentsJ P Gisbert, J L Gisbert, S Marcos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2000
Value of quantitative serology for confirmation of Helicobacter pylori eradication: an 18-month follow-up studyJ P Gisbert, M Blanco, L M Benito, et al.
European Journal of Gastroenterology & Hepatology|November 3, 2001
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsiaJ P Gisbert, S Marcos, J L Gisbert, et al.
The American Journal of Gastroenterology|October 5, 2012
Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel diseaseJ P Gisbert, J R Villagrasa, A Rodríguez-Nogueiras, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2015
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failedJ P Gisbert, A C Marín, A G McNicholl, et al.
Atencion Primaria|November 13, 2002
[Study of the validity of "rapid" serology in diagnosing Helicobacter pylori infection]J P Gisbert, M A Vázquez, J Cantero, et al.
Journal of Crohn'S & Colitis|April 27, 2012
Severe adalimumab-induced thrombocytopenia in a patient with Crohn's diseaseM J Casanova, M Chaparro, S Martínez, et al.
Medicina Clinica|May 5, 1999
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments]J P Gisbert, D Boixeda, C Martín de Argila, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2002
Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?J P Gisbert, E A Jones, J M Pajares, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2005
Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infectionJ P Gisbert, L García-Buey, J M Pajares, et al.
Pageof 22

Showing results (61-70 of 211) with videos related to

Sort By:
Pageof 22
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 20, 2004
Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatmentsJ P Gisbert, J L Gisbert, S Marcos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2000
Value of quantitative serology for confirmation of Helicobacter pylori eradication: an 18-month follow-up studyJ P Gisbert, M Blanco, L M Benito, et al.
European Journal of Gastroenterology & Hepatology|November 3, 2001
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsiaJ P Gisbert, S Marcos, J L Gisbert, et al.
The American Journal of Gastroenterology|October 5, 2012
Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel diseaseJ P Gisbert, J R Villagrasa, A Rodríguez-Nogueiras, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2015
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failedJ P Gisbert, A C Marín, A G McNicholl, et al.
Atencion Primaria|November 13, 2002
[Study of the validity of "rapid" serology in diagnosing Helicobacter pylori infection]J P Gisbert, M A Vázquez, J Cantero, et al.
Journal of Crohn'S & Colitis|April 27, 2012
Severe adalimumab-induced thrombocytopenia in a patient with Crohn's diseaseM J Casanova, M Chaparro, S Martínez, et al.
Medicina Clinica|May 5, 1999
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments]J P Gisbert, D Boixeda, C Martín de Argila, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2002
Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?J P Gisbert, E A Jones, J M Pajares, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2005
Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infectionJ P Gisbert, L García-Buey, J M Pajares, et al.
Pageof 22